Literature DB >> 10722167

Synthesis and pharmacology of a hybrid cannabinoid.

J W Huffman1, J Lu, D Dai, A Kitaygorodskiy, J L Wiley, B R Martin.   

Abstract

A pentacyclic hybrid cannabinoid (4) has been synthesized, which combines structural elements of traditional cannabinoids and cannabmimetic indoles. Cannabinoid 4 contains a 1-pentylindole structure fused to the 2,3-positions of the partially reduced hydroxydibenzopyran system of THC. The successful approach to 4 employed 9-benzoyl-5,7-dimethoxy-1,2,3,4-tetrahydrocarbazole (17) as the starting material. Dehydrogenation to carbazole 18, followed by demethylation and condensation with trans-p-menthadienol gave N-benzoyl hybrid cannabinoid 22, N-alkylation of which afforded target cannabinoid 4. The hybrid cannabinoid had affinity for the CB1 receptor approximately equal to that of delta8-THC (Ki = 19.3+/-3 nM), and shows comparable potency in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722167     DOI: 10.1016/s0968-0896(99)00305-3

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

Review 1.  Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.

Authors:  Slava Rom; Yuri Persidsky
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-08       Impact factor: 4.147

2.  The CB2-preferring agonist JWH015 also potently and efficaciously activates CB1 in autaptic hippocampal neurons.

Authors:  N Murataeva; K Mackie; A Straiker
Journal:  Pharmacol Res       Date:  2012-08-14       Impact factor: 7.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.